Missouri Electric Commission to Sell $105 Million of Refunding Bonds
By Stephen Nakrosis
The Missouri Joint Municipal Electric Utility Commission plans to sell $105 million in power project revenue refunding bonds.
The Commission, which does business as the Missouri Electric Commission, will use proceeds from the offering to refund previously issued bonds and to pay issuance costs.
The tax-exempt bonds are not subject to redemption before their respective stated maturity dates, a document posted Tuesday on MuniOS said. Maturity dates begin on Jan. 1, 2026 and continue through Jan. 1, 2034. The bonds are expected to price on Sept.17 with delivery on Oct. 3, according a roadshow presentation on MuniOS.
The bonds will be secured with revenues received from the Plum Point Project, the Commission said. The Plum Point facility is located in Arkansas, and the Commission is entitled to about 150MW of capacity, which it assigns to its members in Missouri.
The bonds have been rated A3 with a stable outlook by Moody's Investors Service and A with a stable outlook by Fitch Ratings.
RBC Capital Markets is listed as the offering's senior manager.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 11, 2024 15:42 ET (19:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk